OI
BIIB icon

Oakbrook Investments’s Biogen BIIB Stock Holding History

Oakbrook Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$403K Sell
1,275
-2,200
-63% -$668K 1.03% 41
2019
Q4 		$1.03M Sell
3,475
-3,975
-53% -$1.1M 0.21% 117
2019
Q3 		$1.74M Buy
7,450
+874
+13% +$204K 0.11% 133
2019
Q2 		$1.54M Sell
6,576
-7,615
-54% -$1.76M 0.09% 173
2019
Q1 		$3.35M Sell
14,191
-46,749
-77% -$14.7M 0.2% 75
2018
Q4 		$18.3M Buy
60,940
+11,635
+24% +$3.71M 1.24% 21
2018
Q3 		$17.4M Buy
49,305
+1,374
+3% +$473K 0.97% 25
2018
Q2 		$13.9M Sell
47,931
-1,034
-2% -$291K 0.88% 28
2018
Q1 		$13.4M Sell
48,965
-2,570
-5% -$798K 0.83% 28
2017
Q4 		$16.4M Sell
51,535
-1,435
-3% -$460K 1.04% 26
2017
Q3 		$16.6M Buy
52,970
+40,395
+321% +$12M 1.07% 26
2017
Q2 		$3.41M Sell
12,575
-1,550
-11% -$410K 0.23% 83
2017
Q1 		$3.86M Buy
14,125
+775
+6% +$219K 0.25% 74
2016
Q4 		$3.79M Sell
13,350
-2,500
-16% -$741K 0.25% 75
2016
Q3 		$4.96M Sell
15,850
-3,700
-19% -$1.1M 0.3% 69
2016
Q2 		$4.73M Sell
19,550
-3,800
-16% -$1M 0.26% 76
2016
Q1 		$6.08M Buy
23,350
+1,416
+6% +$374K 0.39% 61
2015
Q4 		$6.72M Sell
21,934
-2,680
-11% -$770K 0.43% 58
2015
Q3 		$7.18M Sell
24,614
-250
-1% -$82.6K 0.47% 54
2015
Q2 		$10M Buy
24,864
+1,200
+5% +$482K 0.61% 43
2015
Q1 		$9.99M Sell
23,664
-125
-0.5% -$49.3K 0.54% 46
2014
Q4 		$8.07M Sell
23,789
-2,650
-10% -$857K 0.43% 50
2014
Q3 		$8.75M Sell
26,439
-26,650
-50% -$8.79M 0.47% 50
2014
Q2 		$16.7M Sell
53,089
-11,075
-17% -$3.33M 0.51% 55
2014
Q1 		$19.6M Sell
64,164
-7,850
-11% -$2.49M 0.62% 43
2013
Q4 		$20.1M Sell
72,014
-7,611
-10% -$1.97M 0.56% 48
2013
Q3 		$19.2M Sell
79,625
-3,150
-4% -$705K 0.56% 49
2013
Q2 		$17.8M Buy
+82,775
New +$17.7M 0.52% 44

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Oakbrook Investments's BIIB Position: Q1 2020 in Review

Oakbrook Investments reduced its Biogen (BIIB) stake by 63% in Q1 2020, selling an estimated $668K and leaving 1,275 shares worth $403K. The position accounts for 1.03% of the portfolio, ranked #41.

Oakbrook Investments first reported a position in BIIB in Q2 2013 and has held it in 28 quarters since. The position peaked at $20.1M in Q4 2013. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Oakbrook Investments held 1,275 shares of Biogen worth $403K as of Q1 2020.
  • Oakbrook Investments sold 2,200 Biogen shares in Q1 2020, an estimated $668K.
  • Biogen made up 1.03% of Oakbrook Investments's portfolio in Q1 2020, its #41 holding.
  • Oakbrook Investments first reported a position in Biogen in Q2 2013 and has held it in 28 quarters since.
  • Oakbrook Investments's Biogen position peaked at $20.1M in Q4 2013.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.